Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free route for 4-trifluoromethylnicotinic acid. High purity, scalable process for flonicamid production. Cost-effective agrochemical intermediate manufacturing solution.
Patent CN106191089B accelerates 5-AVA yield via transporter overexpression, offering cost-effective supply chain solutions for global pharmaceutical and chemical manufacturers.
Patent CN114105772B details a high-yield synthesis route for 2-chloro-4-fluoro-5-nitrobenzoic acid offering significant supply chain stability and cost optimization for global buyers.
Patent CN111285768B introduces a recyclable polyionic liquid copper catalyst for efficient asymmetric Henry reactions in water, offering significant cost reduction in chiral catalyst manufacturing.
Patent CN110714002B discloses a highly efficient nitrilase mutant for synthesizing (S)-3-cyano-5-methylhexanoic acid, offering superior stereoselectivity and solubility for scalable pharmaceutical manufacturing.
Patent CN118241230B reveals advanced Kolbe electrolysis for musk ketone precursors. Achieve higher yield and selectivity with optimized electrochemical synthesis.
Patent CN112794837B reveals a high-yield isochroman synthesis using TPSCA. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106674040B details catalyst-free N-aryl amide synthesis offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN103288630A details a novel synthesis of Sodium Danshensu from L-Tyrosine. This report analyzes the DKR strategy for cost-effective, high-purity API intermediate manufacturing.
Patent CN100522920C reveals a high-yield organolithium method for 4-bromo-2,6-difluorobenzoic acid, offering superior regioselectivity and cost reduction for pharmaceutical intermediates.
Novel Ru-catalyzed asymmetric hydrogenation route for Niraparib intermediate. High yield, scalable process for pharmaceutical supply chains.
Patent CN108424367B reveals a metal-free domino reaction for propiolic acids. This breakthrough offers cost reduction in pharmaceutical intermediates manufacturing with high purity.
Advanced 4-step synthesis of Shikimic Acid from crotonaldehyde. Patent CN102633629B offers high purity >98% ee, reduced waste, and reliable supply chain solutions.
Patent CN108727187A details a high-purity synthesis route for herbicide intermediates. This report analyzes cost reduction and supply chain reliability for global procurement.
Patent CN111205251B details a novel synthesis for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-carbamic acid benzyl ester, offering significant cost reduction and scalable manufacturing for chiral catalysts.
Novel lithiation method ensures high purity and cost efficiency for 2,6-dichlorophenylboronic acid supply chain optimization and reliable pharmaceutical intermediates sourcing globally.
Patent CN1497048A details a biocatalytic route for chiral intermediates. Offers high ee and scalable production for pharma applications.
Novel metal-free synthesis of 6-fluoroimidazo[1,2-a]pyridine-3-carboxylic acid offers high purity and scalable production for pharmaceutical intermediates.
Novel patent CN110894186B details a safe, high-yield route for pimavanserin intermediates using carbon dioxide, eliminating toxic phosgene and reducing impurities for cost-effective manufacturing.
Novel ionic liquid synthesis for YM-905 intermediate. High yield, low toxicity, scalable production for global supply chains.